Suppr超能文献

摩洛哥患者亨廷顿病的临床和遗传数据。

Clinical and genetic data of Huntington disease in Moroccan patients.

作者信息

Bouhouche Ahmed, Regragui Wafaa, Lamghari Hind, Khaldi Khadija, Birouk Nazha, Lytim Safaa, Bellamine Soufiane, Kriouile Yamna, Bouslam Naima, Haddou El Hachmia Ait Ben, Faris Mustapha Alaoui, Benomar Ali, Yahyaoui Mohamed

机构信息

Equipe de Recherche sur les Maladies Neurodégénératives, Faculté de Médecine et de Pharmacie, Université Mohammed V de Rabat, Morocco; Service de Neurologie et de Neurogénétique, Hôpital des Spécialités de Rabat, Morocco.

Centre de diagnostic polyvalent, Salé, Morocco.

出版信息

Afr Health Sci. 2015 Dec;15(4):1232-8. doi: 10.4314/ahs.v15i4.23.

Abstract

BACKGROUND

Huntington's disease (HD) occurs worldwide with prevalence varying from 0.1 to 10/100,000 depending of the ethnic origin. Since no data is available in the Maghreb population, the aim of this study is to describe clinical and genetic characteristics of Huntington patients of Moroccan origin.

METHODS

Clinical and genetics data of 21 consecutive patients recruited from 2009 to 2014 from the outpatient clinic of six medical centers were analyzed. Statistical analysis was performed using descriptive statistics.

RESULTS

Twenty one patients from 17 families were diagnosed positive for the IT15 gene CAG expansion. Clinical symptoms were predominantly motor (19/21). Twelve patients had psychiatric and behavioral disorders, and 11 patients had cognitive disorders essentially of memory impairment. Analysis of genetic results showed that 5 patients had reduced penetrant (RP) alleles and 16 had fully penetrant (FP) alleles. The mean CAG repeat length in patients with RP alleles was 38.4 ± 0.54, and 45.37 ± 8.30 in FP alleles. The age of onset and the size of the CAG repeat length showed significant inverse correlation (p <0.001, r = -0.754).

CONCLUSION

Clinical and genetic data of Moroccan patients are similar to those of Caucasian populations previously reported in the literature.

摘要

背景

亨廷顿舞蹈症(HD)在全球范围内均有发生,其患病率因种族不同而在0.1至10/100,000之间波动。由于目前尚无关于马格里布人群的相关数据,本研究旨在描述摩洛哥裔亨廷顿舞蹈症患者的临床和遗传特征。

方法

对2009年至2014年期间从六个医疗中心的门诊连续招募的21例患者的临床和遗传学数据进行分析。采用描述性统计进行统计分析。

结果

来自17个家庭的21例患者被诊断为IT15基因CAG扩增阳性。临床症状主要为运动症状(19/21)。12例患者有精神和行为障碍,11例患者有主要为记忆障碍的认知障碍。基因结果分析显示,5例患者具有低外显率(RP)等位基因,16例具有完全外显率(FP)等位基因。RP等位基因患者的平均CAG重复长度为38.4±0.54,FP等位基因患者为45.37±8.30。发病年龄与CAG重复长度大小呈显著负相关(p<0.001,r = -0.754)。

结论

摩洛哥患者的临床和遗传数据与文献中先前报道的白种人群的数据相似。

相似文献

1
Clinical and genetic data of Huntington disease in Moroccan patients.
Afr Health Sci. 2015 Dec;15(4):1232-8. doi: 10.4314/ahs.v15i4.23.
2
Clinical and genetic features of Huntington disease in Sri Lanka.
BMC Neurol. 2013 Dec 5;13:191. doi: 10.1186/1471-2377-13-191.
4
Molecular analysis and prevalence of Huntington disease in northwestern Iran.
Turk J Med Sci. 2017 Dec 19;47(6):1880-1884. doi: 10.3906/sag-1510-25.
5
Clinical and genetic characteristics in patients with Huntington's disease from China.
Neurol Res. 2016 Oct;38(10):916-20. doi: 10.1080/01616412.2016.1214555. Epub 2016 Jul 29.
6
Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
Bipolar Disord. 2015 Jun;17(4):403-8. doi: 10.1111/bdi.12289. Epub 2015 Feb 26.
7
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Lancet Neurol. 2018 Nov;17(11):986-993. doi: 10.1016/S1474-4422(18)30294-1. Epub 2018 Sep 19.
9
Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testing.
J Neurol Sci. 2013 Dec 15;335(1-2):101-4. doi: 10.1016/j.jns.2013.08.037. Epub 2013 Sep 3.
10
Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
J Hum Genet. 2012 Dec;57(12):796-803. doi: 10.1038/jhg.2012.120. Epub 2012 Oct 11.

引用本文的文献

2
Biomarkers of neurodegeneration across the Global South.
Lancet Healthy Longev. 2024 Oct;5(10):100616. doi: 10.1016/S2666-7568(24)00132-6. Epub 2024 Oct 3.
4
Dementia in Africa: Current evidence, knowledge gaps, and future directions.
Alzheimers Dement. 2022 Apr;18(4):790-809. doi: 10.1002/alz.12432. Epub 2021 Sep 27.
5
"Clinical Profile of Genetically Proven Huntington's Disease Patients from Eastern India".
Ann Indian Acad Neurol. 2020 Mar-Apr;23(2):195-200. doi: 10.4103/aian.AIAN_505_19. Epub 2020 Feb 25.
6
From sexual orientation to cochlear transplants in a tropical environment.
Afr Health Sci. 2015 Dec;15(4):i-iii. doi: 10.4314/ahs.v15i4..

本文引用的文献

1
Preliminary analysis of Huntington's Disease in South Korea.
J Huntingtons Dis. 2013;2(1):83-7. doi: 10.3233/JHD-120040.
2
Clinical and genetic features of Huntington disease in Sri Lanka.
BMC Neurol. 2013 Dec 5;13:191. doi: 10.1186/1471-2377-13-191.
3
[Juvenile Huntington disease: A case study].
Arch Pediatr. 2013 Oct;20(10):1161-3. doi: 10.1016/j.arcped.2013.06.032. Epub 2013 Aug 27.
5
Role of cerebral cortex in the neuropathology of Huntington's disease.
Front Neural Circuits. 2013 Feb 18;7:19. doi: 10.3389/fncir.2013.00019. eCollection 2013.
6
The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Mov Disord. 2012 Aug;27(9):1083-91. doi: 10.1002/mds.25075. Epub 2012 Jun 12.
7
Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Eur J Med Genet. 2011 Jul-Aug;54(4):e413-8. doi: 10.1016/j.ejmg.2011.04.002. Epub 2011 Apr 23.
8
Huntington disease (chorea) in the middle East.
Sultan Qaboos Univ Med J. 2009 Apr;9(1):16-23. Epub 2009 Mar 16.
9
A retrospective study of the impact of lifestyle on age at onset of Huntington disease.
Mov Disord. 2010 Jul 30;25(10):1444-50. doi: 10.1002/mds.23108.
10
Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics.
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S135-8. doi: 10.1016/S1353-8020(09)70800-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验